中国肾脏移植活体捐献供者医学评估临床指南(2023版)  

Clinical guidelines for medical evaluations of living donors for kidney transplantation in China(2023 edition)

作　　者：中华医学会器官移植学分会 中国医疗保健国际交流促进会肾脏移植学分会 林涛[2] 王显丁[3] 张帆[3] Branch of Organ Transplantation,Chinese Medical Association;Branch of Kidney Transplantation,China International Exchange and Promotive Association for Medical and Health Care;Lin Tao(不详;Department of Urology,West China Hospital,Sichuan University,Chengdu 610041)

机构地区：[1]不详 [2]四川大学华西医院泌尿外科,成都610041 [3]四川大学华西医院,成都610041

出　　处：《中华器官移植杂志》2024年第12期839-849,共11页Chinese Journal of Organ Transplantation

基　　金：国家重点研发计划(2023YFC2505900);四川省科技计划项目(2023YFS0256&2019YJ0133);四川大学华西医院临床研究孵化项目(2021HXFH007)。

摘　　要：对肾脏移植潜在活体捐献供者进行医学评估和选择的主要目的在于确保供者符合肾脏捐献的医学要求、保证供者在捐献后的长期身心健康、同时兼顾受者的移植效果。为了更好地指导肾脏移植医务工作者规范地对潜在供者进行医学评估和选择,中华医学会器官移植学分会组织了国内肾脏移植领域相关专家,按照《牛津大学循证医学中心分级2009版》,针对肾脏移植活体捐献供者医学评估和选择的16个临床问题,给出了详细的循证医学推荐,旨在指导临床实践,提升我国供者医学评估和选择的水平,促进我国活体器官移植事业发展。The primary purpose of medical evaluations and selections of potential living kidney transplant(KT)donors is to ensure that the donors fulfill the medical requirements for kidney donation,safeguard the long-term physical and mental health of donors after donation and to take into account transplant effect of recipient.For better guiding KT medical workers in conducting standardized medical evaluations and selections of potential donors,Branch of Organ Transplantation,Chinese Medical Association convened the relevant KT experts in China.Based upon the Oxford University Evidence-Based Medicine Center Classification 2009,detailed evidence-based medicine recommendations were provided for 16 clinical issues in medical evaluations and selections of living KT donors,aiming to guide clinical practices,boost the overall level of medical evaluations and selections of donors and promote the development of living organ transplantation in China.

关 键 词：肾脏移植 器官捐献 活体供器官 活体供者评估 预后 危险因素 指南 

分 类 号：R699.2[医药卫生—泌尿科学]